2026 ICD-10-CM Diagnosis Code G93.42Megalencephalic leukoencephalopathy with subcortical cysts
ICD-10-CM Codes›G00–G99›G89-G99›G93
- Billable — Valid for Submission
- Chronic Condition
G93.42 is a billable ICD-10-CM diagnosis code for megalencephalic leukoencephalopathy with subcortical cysts. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 974 through 976. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other nervous system disorders (often hereditary or degenerative).
Code Identity
Code Classification
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Leukoencephalopathy - See Also: Encephalopathy; - G93.49
- megalencephalic, with subcortical cysts - G93.42
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Leukoencephalopathy
- megalencephalic, with subcortical cysts
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Code History & ChangesHistory
Replacement G93.42 replaces the following previously assigned code(s):
- G93.49 - Other encephalopathy
Questions About G93.42Overview
Is G93.42 (Other and unspecified encephalopathy) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report megalencephalic leukoencephalopathy with subcortical cysts on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does G93.42 group to?
When megalencephalic leukoencephalopathy with subcortical cysts is the principal diagnosis on an inpatient stay, it groups to MS-DRG 974, 975, 976, with relative weights from 0.8945 to 2.8860 depending on complications. Higher weights mean higher Medicare reimbursement.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
